Dilan Athauda

Distribution of insulin in trigeminal nerve and brain after intranasal administration

Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes

Parkinson's disease

Biological and Clinical Implications of Comorbidities in Parkinson’s Disease

Hallmarks of aging: An expanding universe

Ageing as a risk factor for neurodegenerative disease

Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1

The Therapeutic Potential of Metformin in Neurodegenerative Diseases

The Discovery and Development of Liraglutide and Semaglutide

Non-motor features of Parkinson disease

The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease

Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model

Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer

Quadruple Decision Making for Parkinson’s Disease Patients: Combining Expert Opinion, Patient Preferences, Scientific Evidence, and Big Data Approaches to Reach Precision Medicine

Diagnosis and Treatment of Parkinson Disease

Progression marker of Parkinson’s disease: a 4-year multi-site imaging study

Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?

In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Black Phosphorus Nanosheets as a Neuroprotective Nanomedicine for Neurodegenerative Disorder Therapy

Roles of Regulatory T Cell-Derived Extracellular Vesicles in Human Diseases

Reactive Oxygen Species (ROS)-Based Nanomedicine

Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD

The Linked Clinical Trials initiative (LCT) for Parkinson's disease

Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

Post hoc analysis of the Exenatide‐ PD trial—Factors that predict response

Insulin resistance and Parkinson’s disease: A new target for disease modification?

The ongoing pursuit of neuroprotective therapies in Parkinson disease

Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

GBA-Associated Parkinson’s Disease: Progression in a Deep Brain Stimulation Cohort

Is Exenatide a Treatment for Parkinson’s Disease?

Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease

What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson’s Disease: A Post Hoc Analysis